Showing 1 - 7 results of 7 for search 'Bao-Dong Qin', query time: 0.03s Refine Results
  1. 1
    Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus crizotinib

    Case report: Aumolertinib plus gumarontinib in a patient with EGFR mutated non-small-cell lung cancer harboring acquired MET amplification following progression on afatinib plus cr... by Jia-Jun Hui, Sheng-Jun Ding, Bao-Dong Qin, Ning Ding

    Published 2025-02-01
    Get full text
    Article
  2. 2
    Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy

    Immunotherapy-based regimens for patients with EGFR-mutated non-small cell lung cancer who progressed on EGFR-TKI therapy by Ying Wu, Yan Ling, Bao-Dong Qin, Xiao-Dong Jiao, Ling-Yan Yuan, Yuan-Sheng Zang

    Published 2024-04-01
    Get full text
    Article
  3. 3
    New clinical trial design in precision medicine: discovery, development and direction

    New clinical trial design in precision medicine: discovery, development and direction by Xiao-Peng Duan, Bao-Dong Qin, Xiao-Dong Jiao, Ke Liu, Zhan Wang, Yuan-Sheng Zang

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer

    Effects of concomitant proton pump inhibitor use on immune checkpoint inhibitor efficacy among patients with advanced cancer by Bao-Dong Qin, Xiao-Dong Jiao, Xin-Cheng Zhou, Bin Shi, Jian Wang, Ke Liu, Ying Wu, Yan Ling, Yuan-Sheng Zang

    Published 2021-01-01
    Get full text
    Article
  5. 5
    Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy

    Prognostic value of tumor mutation burden in patients with advanced gastric cancer receiving first-line chemotherapy by Xiao-Peng Duan, Ke Liu, Xiao-Dong Jiao, Bao-Dong Qin, Bing Li, Xi He, Yan Ling, Ying Wu, Shi-Qi Chen, Yuan-Sheng Zang

    Published 2023-01-01
    Get full text
    Article
  6. 6
    The Association Between Tumor Burden and the Efficacy of Immunotherapy Among Patients With Non-small Cell Lung Cancer

    The Association Between Tumor Burden and the Efficacy of Immunotherapy Among Patients With Non-small Cell Lung Cancer by Jia-Jun Hui MD, Han-Lu Yan PhD, Sheng-Jun Ding MD, Bao-Dong Qin PhD, Xiao-Dong Jiao PhD, Yuan-Sheng Zang PhD

    Published 2025-02-01
    Get full text
    Article
  7. 7
    Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway)

    Targeted therapy for intractable cancer on the basis of molecular profiles: An open-label, phase II basket trial (Long March Pathway) by Xiao-Dong Jiao, Bao-Dong Qin, Zhan Wang, Ke Liu, Ying Wu, Yan Ling, Wen-Xing Qin, Miao-Miao Wang, Ling-Yan Yuan, Savio George Barreto, Anthony W. Kim, Kimberley Mak, Hao Li, Yuan-Yuan Xu, Xiao-Ming Qiu, Min Wu, Min Jin, Li-Chao Xu, Yi Zhong, Hui Yang, Xue-Qin Chen, Yu Zeng, Jun Shi, Wen-Yu Zhu, Qing-Qing Ding, Wei Jia, Su-Fen Liu, Jun-Jing Zhou, Hong Shen, Shi-Hua Yao, Zhao-Ji Guo, Ting Li, Pei-Juan Zhou, Xue-Wei Dong, Wen-Feng Lu, Robert L. Coleman, Mehmet Akce, Chérif Akladios, Francesco Puccetti, Yuan-Sheng Zang

    Published 2023-02-01
    Get full text
    Article

Search Tools: